Freitag Gregory Gene 4
4 · Axogen, Inc. · Filed Sep 7, 2023
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Freitag Gregory Gene
DirectorCFO
Transactions
- Award
Stock Option (right to purchase)
2023-09-01+20,436→ 20,436 totalExercise: $6.30Exp: 2033-09-01→ Common Stock (20,436 underlying) - Award
Restricted Stock Units
2023-09-01+11,904→ 11,904 total→ Common Stock (11,904 underlying)
Footnotes (2)
- [F1]Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units of which shares will be delivered to the reporting person upon vesting.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.